[1] Delbeke D, Sandier MP. The role of hybrid camera in oncology[J]. Semin Nucl Med, 2000,30(4):268-280.
[2] Delbeke D, Cerci R, Martin WH, et al. Comparison of iterative reconstruction and back projection algorithm to detect lesion on FDG images obtained with a hybrid camera in patients with known or suspected malignancies[J]. J Nucl Med,2000,41:197.
[3] Meike SR, Hutton BF, Baily DL, et al. Accelerated EM reconstruction in total body PET:Potential for improving tumour detectability[J]. Phys Med Biol, 1994, 39:1689.
[4] Bleckman C, Dose J, Bohuslavizki KH, et al.Effect of attenuation correction on lesion detectability in FDG PET of breast cancer[J]. J Nucl Med, 1999, 40:2021-2024.
[5] Shreve P, Steventon RS, Deters E, et al. FDG img-ing of neoplasms using a dual head SPECT camera operated in coincidence mode[J]. Eur J Nucl Med, 1997, 24:860.
[6] Tasumi M, Yutani K, Watanabe Y, et al. Feasibility of fluorodeoxyglucose dual-head camera coincidence imaging in the evaluation of lung cancer:comparison with FDG PET[J]. J Nucl Med, 1999,40:566-573.
[7] Weber WA, Neverve J, Sklarek J, et al. Imaging of lung cancer with fluorine-18 fluorodeoxyglucose:comparison of adual-head gamma camera in coincidence mode with a full-ring positron emission tomography system[J]. EurJ Nucl Med, 1999, 26:388-395.
[8] Zimny M, Kaiser HJ, Cremerius U, et al. Dual-head gamma camera 2-[fluorine-18] -fluoro-2-deoxy-D-glucose positron emission tomography in oneological patients:effects of nonuniform attenuation correction on lesion detection[J]. Eur J Nucl Med, 1999, 26(8):818-823.
[9] Engel H, Steinert H, Buck A, et al. Whole body PET:Physiological and artifactual fluorodeoxyglucose accumulation[J]. J Nuel Med, 1996, 36:441-446.
[10] Pai M, Park CH, Suh JH, et al. Fluorine-18-Fluorodeoxygul-cose imaging using dual-head coincidence positroemission tomography without attenuation correction in patients with head and neck cancer[J]. Clin Nucl Med, 1999, 24(7):495-500.
[11] Shreve PD, Steventon RS, Deters EC, et al. Oncologic daginosis with FDG imaging dual head coincidence gamma cameraver suspositron emission tomographic scanner[J]. Radiology, 1998, 207(2):431-437.
[12] Drane WE, Abbott FD, Nicole MW, et al. Technology for FDG SPECT with a relatively inexpensive gamma camera[J]. Radiology, 1994, 191:461-465.
[13] Landoni C, Gianolli L, Lucignani G, et al. Comparison of dual-head coincidence PET versus ring PET in tumor patients[J]. J Nucl Med, 1999, 40(10):1617-1622.
[14] Yutani K, Tatsumi M, Shiba E, et al. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axilliary lymph node metastasis[J]. J Nucl Med, 1999, 40(6):1003-1007.
[15] Holle LH, Trampert L, Lung Kurt S, et al. Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT[J]. J Nucl Med, 1996, 37:615-622.